In Vivo Efficacy and Toxicity Studies of a Novel Antibacterial Agent: 14-O-[(2-Amino-1,3,4-thiadiazol-5-yl)Thioacetyl] Mutilin
Open Access
- 24 March 2015
- Vol. 20 (4) , 5299-5312
Abstract
A new pleuromutilin derivative with excellent antibacterial activity, 14-O-[(2-amino-1,3,4-thiadiazol-5-yl) thioacetyl] mutilin (ATTM), may serve as a possible lead compound for the development of antibacterial drugs. However, in vivo efficacy and toxicity evaluations of this compound have not been performed. In this study, we evaluated the efficacy of ATTM by measuring the survival of mice after a lethal challenge with methicillin-resistant Staphylococcus aureus (MRSA), and the 50% effective dose (ED50) was 5.74 mg/kg by the intravenous route. In an oral single-dose toxicity study, ATTM was orally administered to mice at different doses and the 50% lethal dose (LD50) was calculated to be 2304.4 mg/kg by the Bliss method. The results of the subchronic oral toxicity study in rats showed no mortality, exterior signs of toxicity, or differences in the total weight gain or relative organ weights between the treated groups and control group after administration. The hematological and serum biochemical data showed no differences between the treated and control groups, except for the levels of alkaline phosphatase (ALP), creatinine (CR) and blood glucose (GLU), which were significantly different in the high-dose group. The differences in the histopathological findings between the treated groups and the control group were not considered to be treatment-related. Our results indicated that the no observed adverse effect level (NOAEL) for ATTM was 5 mg/kg in this study.Keywords
This publication has 16 references indexed in Scilit:
- Synthesis and Biological Evaluation of New Pleuromutilin Derivatives as Antibacterial AgentsMolecules, 2014
- Synthesis and Biological Activities of Novel Pleuromutilin Derivatives with a Substituted Thiadiazole Moiety as Potent Drug-Resistant Bacteria InhibitorsJournal of Medicinal Chemistry, 2014
- Design, Synthesis, and Structure–Activity Relationship Studies of Novel Thioether Pleuromutilin Derivatives as Potent Antibacterial AgentsJournal of Medicinal Chemistry, 2014
- A click chemistry approach to pleuromutilin derivatives. Part 3: Extended footprinting analysis and excellent MRSA inhibition for a derivative with an adenine phenyl side chainBioorganic & Medicinal Chemistry Letters, 2014
- A Modeling Framework for the Evolution and Spread of Antibiotic Resistance: Literature Review and Model CategorizationAmerican Journal of Epidemiology, 2013
- Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)Journal of Antimicrobial Chemotherapy, 2012
- Avaliação in vivo do efeito hipocolesterolêmico e toxicológico preliminar do extrato bruto hidroalcoólico e decocção da Vitex megapotamica (Spreng) Moldenke (V. montevidensis Cham.)Revista Brasileira de Farmacognosia, 2009
- Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivityProceedings of the National Academy of Sciences, 2007
- Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulinMolecular Microbiology, 2004
- Antibiotic Substances From BasidiomycetesProceedings of the National Academy of Sciences, 1951